Amedeo Smart

Free Medical Literature Service

 

Amedeo

Neonatology
  Free Subscription

Articles published in
Transfusion
    January 2026
  1. KADIOGLU SIMSEK G, Siyah Bilgin B, Kalayci OK, Tekin MY, et al
    Transfusion of blood products and neonatal outcomes in preterm infants: A retrospective cohort study.
    Transfusion. 2026 Jan 26. doi: 10.1111/trf.70064.
    >> Share

    December 2025
  2. DE WINTER DP, de Haas M, Hulzebos CV, Lukens MV, et al
    Antenatal risk estimation for exchange transfusions in neonates with hemolytic disease of the fetus and newborn in a changing treatment landscape: A multicenter, retrospective cohort study.
    Transfusion. 2025 Dec 30. doi: 10.1111/trf.70056.
    >> Share

  3. VAN DAELEN JH, Bestebroer J, Korsten H, Vermeulen C, et al
    Development and production of allogeneic cord blood-derived red blood cell concentrates for transfusion to extremely preterm neonates, the All-Cord study.
    Transfusion. 2025 Dec 22. doi: 10.1111/trf.70024.
    >> Share

  4. DAVENPORT P, Feldman HA, Kane N, Escobar JR, et al
    Transfusion of adult platelets triggers inflammatory responses in newborn mice through both P-selectin-dependent and -independent mechanisms.
    Transfusion. 2025 Dec 16. doi: 10.1111/trf.70042.
    >> Share

  5. RAJ JG, Shrestha P, Ramatchandirin B, Balamurugan MA, et al
    Red blood cell transfusion exacerbates phlebotomy-induced anemia-associated neuroinflammation in murine neonates.
    Transfusion. 2025 Dec 3. doi: 10.1111/trf.70018.
    >> Share

  6. O'BRIEN K, Abels E, Bakhtary S, George M, et al
    A survey on the use of Rh immune globulin during a nationwide shortage.
    Transfusion. 2025;65:2286-2292.
    >> Share

  7. BLACKALL D, Alcorn K, Parikh P
    Successful outcome of a pregnancy complicated by anti-e and anti-Di(b).
    Transfusion. 2025;65:2423-2426.
    >> Share

    October 2025
  8. NOGUEIRA-SILVA LC, Bordin JO, Abbas SA, Lopes LB, et al
    Concurrent neonatal alloimmune neutropenia and thrombocytopenia: Prevalence and antibody specificity and intensity in a large Brazilian cohort.
    Transfusion. 2025 Oct 5. doi: 10.1111/trf.18429.
    >> Share

    September 2025
  9. HOUBEN NAM, Caram-Deelder C, Lopriore E, Fustolo-Gunnink S, et al
    The whole is greater than the sum of its parts: Rethinking our approach to neonatal transfusion research.
    Transfusion. 2025 Sep 30. doi: 10.1111/trf.18432.
    >> Share

  10. PRAKASH S, Verma A, Sehgal T, Aggarwal M, et al
    Hematological and iron status in infants with Rh hemolytic disease: A prospective cohort study.
    Transfusion. 2025 Sep 25. doi: 10.1111/trf.18430.
    >> Share

  11. KELLY E, Rosenberg M, Gonzalez-Velez J, Bakhtary S, et al
    Characterization of a population with pregnancy potential and anti-K alloimmunization in the United States.
    Transfusion. 2025;65:1567-1573.
    >> Share

    August 2025
  12. GONZALEZ-RESINA R, Herrero-Gutierrez M, Gomez-Segui I, Martinez-Nieto J, et al
    Rare onset of congenital thrombotic thrombocytopenic purpura during pregnancy: A novel ADAMTS13 gene variant.
    Transfusion. 2025 Aug 19. doi: 10.1111/trf.18379.
    >> Share

  13. TRUCCO BOGGIONE C, Benech C, Pigozzi MJ, Orlandi MF, et al
    Alloanti-D in a DBT pregnant woman responsible for hemolytic disease of the fetus and newborn: Molecular study and genetic counseling.
    Transfusion. 2025 Aug 3. doi: 10.1111/trf.18369.
    >> Share

    June 2025
  14. LAMOTHE M, Beltempo M, Lapointe A, Villeneuve A, et al
    Current red blood cell and platelet transfusion practices in Canadian neonatal intensive care units.
    Transfusion. 2025 Jun 9. doi: 10.1111/trf.18305.
    >> Share

    May 2025
  15. ALKHATEB R, Mazzolini K, Prajapati VP, Harrison C, et al
    How I do it: An institutional protocol for the management of RhD negative women who receive RhD positive blood.
    Transfusion. 2025;65 Suppl 1:S320-S327.
    >> Share

    April 2025
  16. GREGER N, Xu XZ, Doescher A, Hassenpflug W, et al
    Alloimmunization against platelet-specific antigen Dik on glycoprotein IIb in a case of fetal-neonatal alloimmune thrombocytopenia.
    Transfusion. 2025 Apr 17. doi: 10.1111/trf.18194.
    >> Share

  17. BABACAN A, Sarklioglu SS, Cavus K, Sarici SU, et al
    Several features of newborns following intrauterine intravascular blood transfusion for fetal hemolytic disease caused by anti-D alloimmunization.
    Transfusion. 2025 Apr 10. doi: 10.1111/trf.18248.
    >> Share

  18. GREEN RW, Cotton BA
    Neonatal trauma resuscitation: Successful use of low-titer O+ whole blood in a 4-day-old infant with hemorrhagic shock.
    Transfusion. 2025 Apr 9. doi: 10.1111/trf.18233.
    >> Share

  19. MADHOU A, Lloyd LG, Mundey N, Nell EM, et al
    Adverse outcomes after red blood cell transfusion in very low birth weight infants in a resource-restricted hospital.
    Transfusion. 2025 Apr 7. doi: 10.1111/trf.18244.
    >> Share

    March 2025
  20. WILHELM K, Lauer C, Rangwala R, Zadeh T, et al
    A prehospital protocol for transfusion of low-titer O-positive whole blood in patients with hemorrhagic shock in Los Angeles County: Modeling the risk of hemolytic disease of the fetus and newborn.
    Transfusion. 2025 Mar 1. doi: 10.1111/trf.18184.
    >> Share

    January 2025
  21. NELSON O, Jones R, Moldenhauer JS, Rintoul NE, et al
    Cord blood for autologous transfusion in infants with congenital anomalies: Volumes, sterility, and stability during storage.
    Transfusion. 2025 Jan 14. doi: 10.1111/trf.18134.
    >> Share

  22. DELBAUGH RM, Thomas B, Gower BJ, Condict B, et al
    Double trouble: A baby with concurrent hemolytic disease of the fetus and newborn and neonatal alloimmune thrombocytopenia.
    Transfusion. 2025 Jan 4. doi: 10.1111/trf.18120.
    >> Share

  23. THORUP E, Clausen FB, Brodersen T, Dellgren CD, et al
    Evaluation of the clinical effect of a nationwide implementation of targeted routine antenatal anti-D prophylaxis in Denmark.
    Transfusion. 2025;65:29-37.
    >> Share

    December 2024
  24. ADKINS BD, Booth GS, Fasano RM, Gehrie EA, et al
    Eliminating leukocyte reduction for whole blood: Is it premature to consider this paradigm-changing practice?
    Transfusion. 2024 Dec 22. doi: 10.1111/trf.18113.
    >> Share

  25. BIENZ M, Constanzo-Yanez J, Baillargeon N, Leiva-Torres GA, et al
    Planning antepartum directed donations in preparation for neonatal cardiac surgery in the absence of compatible donors.
    Transfusion. 2024 Dec 2. doi: 10.1111/trf.18087.
    >> Share

    October 2024
  26. JACOBS JW, Booth GS, Moise KJ, Adkins BD, et al
    Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United States.
    Transfusion. 2024;64:1870-1880.
    >> Share

    September 2024
  27. GRISELLI M, Said SM, Spinella PC, Evans M, et al
    Use of low titer O whole blood in infants and young children undergoing cardiac surgery with cardiopulmonary bypass.
    Transfusion. 2024 Sep 13. doi: 10.1111/trf.18014.
    >> Share

    July 2024
  28. YAZER MH, Spinella PC, Holcomb JB, Horvath S, et al
    A review of attitudes to urgent RhD-positive transfusions in female patients and the risk for hemolytic disease of the fetus and newborn.
    Transfusion. 2024 Jul 23. doi: 10.1111/trf.17967.
    >> Share

    June 2024
  29. BERTRAND G, Danger Y, Verite F, Sarpentier Guibourg M, et al
    A new platelet alloantigen (Efs(2a)) on glycoprotein GPIIIa leading to neonatal alloimmune thrombocytopenia.
    Transfusion. 2024 Jun 25. doi: 10.1111/trf.17933.
    >> Share

  30. GILMORE LE, Chou ST, Ghavam S, Thom CS, et al
    Consensus transfusion guidelines for a large neonatal intensive care network.
    Transfusion. 2024 Jun 17. doi: 10.1111/trf.17914.
    >> Share

    May 2024

  31. Correction to Comparison of Automated Solid Phase vs Manual Saline Indirect Antiglobulin Test Methodology for non-ABO Antibody Titration: Implications for Perinatal Antibody Monitoring.
    Transfusion. 2024 May 8. doi: 10.1111/trf.17866.
    >> Share

  32. PETERMANN R, Bianchi F, Saib L, Ferre N, et al
    Severe neonatal thrombocytopenia due to anti-HPA-4b alloantibodies: Third report described in a Caucasian mother.
    Transfusion. 2024 May 1. doi: 10.1111/trf.17863.
    >> Share

  33. SHERWOOD MR, Clayton S, Leeper CM, Yazer M, et al
    Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
    Transfusion. 2024;64 Suppl 2:S100-S110.
    >> Share

  34. MALONE JR
    Ethical considerations in the use of RhD-positive blood products in trauma.
    Transfusion. 2024;64 Suppl 2:S4-S10.
    >> Share

  35. SUSILA S, Ilmakunnas M, Lauronen J, Vuorinen P, et al
    Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland.
    Transfusion. 2024;64 Suppl 2:S119-S125.
    >> Share

  36. OOSTERHOFF JJ, Linty F, Visser R, de Vos T, et al
    Generation of human antibodies targeting human platelet antigen (HPA)-1a.
    Transfusion. 2024;64:893-905.
    >> Share

    April 2024
  37. WILSON B, Davison CL, Lopez GH, Millard GM, et al
    A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system.
    Transfusion. 2024 Apr 30. doi: 10.1111/trf.17205.
    >> Share

  38. HEEGER LE, Houben NAM, Caram-Deelder C, Fustolo-Gunnink SF, et al
    Impact of restrictive platelet transfusion strategies on transfusion rates: A cohort study in very preterm infants.
    Transfusion. 2024 Apr 25. doi: 10.1111/trf.17844.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016